Join to View Full Profile
1 Eaton PlaceWorcester, MA 01608
Phone+1 806-341-2110
Dr. Zorsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Zorsky is a hematologist in Worcester MA. He received his medical degree from the University of Connecticut and has been in practice for 44 years. He specializes in hematologic oncology and is experienced in hematology and medical oncology. Furthermore, he has more than 10 publications and over 100 citings.
Education & Training
George Washington UniversityFellowship, Hematology and Medical Oncology, 1985 - 1987- George Washington UniversityResidency, Internal Medicine, 1982 - 1984
- George Washington UniversityInternship, Internal Medicine, 1978 - 1979
Uconn School Of MedicineClass of 1978
Certifications & Licensure
ME State Medical License 2021 - 2027
CT State Medical License 2024 - 2026
MA State Medical License 2023 - 2026
TX State Medical License 1995 - 2025
MD State Medical License 2009 - 2023
DE State Medical License 2009 - 2017
OK State Medical License 1981 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Join now to see all
Publications & Presentations
PubMed
- 94 citationsDenosumab for treatment of hypercalcemia of malignancy.Mimi I. Hu, Ilya G. Glezerman, Sophie Leboulleux, Karl L. Insogna, Rasim Gucalp
The Journal of Clinical Endocrinology and Metabolism. 2014-06-10 - 4 citationsNumber of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study.Stephen E. Wright, Kathleen Rewers-Felkins, Imelda S. Quinlin, Catherine A. Phillips, Mary Townsend
Immunological Investigations. 2010-07-23 - 12 citationsTumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients—A Phase I/II StudyStephen E. Wright, Kathleen Rewers-Felkins, Imelda S. Quinlin, Catherine A. Phillips, Mary Townsend
Immunological Investigations. 2009-10-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
